Index: I totally agree with you, however I don't think $50 would be out of the question if we get BTD for tNBC because if Leronlimab works for that indication, there is little reason to think it wouldn't work in connection with CCR5 in the other indications as well. Therefore, with HIV and so many cancer indications, we're really in a fantastically unique position with potential revenue that is unheard of.

Ridicule? I'm not afraid of it. Columbus was ridiculed too, as was the first man who suggested that germs make people sick, not a small man or dwarf living in the pit of your stomach